?Aris Global, a provider of software solutions for the life sciences industry, today announced the general release of agXchange IRT? (inbound receipt and triage) 6.0
Aris Global Expands Its Electronic Exchange Platform
with Release of agXchange IRT™ 6.0
Advanced software solution increases ability to report complete and accurate safety case information on time
AT THE DIA CONFERENCE (Boston, MA) - June 23, 2008: Aris Global, a leading provider of software solutions for the life sciences industry, today announced the general release of agXchange IRT™ (inbound receipt and triage) 6.0, a Web-based, solution for securely and efficiently receiving adverse event information, in different formats, from affiliates, co-development partners, consumers, healthcare providers, investigator sites, CROs, and other stakeholders.
During the DIA 44th Annual Meeting, Aris Global will be demonstrating and presenting agXchange IRT in its booth #834 in the Boston Convention and Exhibition Center.
agXchange IRT is the newest module of the agXchange™ gateway for extended electronic exchange, which also includes agXchange ESM™, an electronic submissions module that supports the import and export of adverse event data in E2B and extended E2B formats. agXchange IRT allows organizations to more closely integrate their affiliate offices into the processes of collecting and submitting safety information even if they do not have access to the central drug safety system. Comprehensive assessment and triage capabilities allow organizations to assess incoming potential safety items prior to case processing.
“Aris Global is committed to the extended electronic exchange gateway as the way organizations can take advantage of the inherent productivity benefits that automated paperless operations deliver,” said Wim Cypers, vice president, product management, Aris Global. “The agXchange IRT module will decrease the amount of time organizations spend collecting and verifying safety information, and will increase their ability to report complete and accurate safety information on time.”
About Aris Global
Aris Global (www.arisglobal.com) is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. More than 300 direct and indirect life science customers rely on the company’s advanced solutions for maintaining regulatory compliance, managing and mitigating risk, improving operational efficiency and easily sharing information on a global basis.
# # #
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.